INDUSTRY NEWS NeoStem Acquires Progenitor Cell Therapy NeoStem, Inc. and Progenitor Cell Therapy LLC announced the closing of their previously announced merger transaction. [NeoStem, Inc. Press Release] A United and Powerful Initiative Launched to Strengthen the UK Economy LifeSciencesUK, a new initiative representing the human healthcare industry, has been launched by the UK’s four key healthcare trade associations to build on the government’s commitment to transform the life sciences environment in the UK. [LifeSciencesUK Press Release] National Marrow Donor Program Selects Velos Inc. for Its New Clinical Data Repository System The National Marrow Donor Program® announced that it has selected Velos Inc., a leading California health care software provider, to supply its new Product Fulfillment and Clinical Data Repository System. It will serve as an enhanced electronic medical record system and is integral to conducting many of the process transactions that support bone marrow and umbilical cord blood transplants between donors and patients. [PR Newswire] Director of Oncology Basic Research at the John Theurer Cancer Center Continues Research Aimed at Improving Allogeneic Blood and Marrow Transplantation Thea Friedman, M.D., associate scientist and director of oncology basic research at the John Theurer Cancer Center at Hackensack University Medical Center was recently awarded a National Institutes of Health-National Cancer Institute RO1 research grant to improve allogeneic blood and marrow transplantation for multiple myeloma patients. [John Theurer Cancer Center Press Release] Pluristem on Track to Proceed to a Phase II/III Clinical Trial in Critical Limb Ischemia (CLI) Under a Joint FDA-EMA Protocol, and a Phase II Clinical Trial in Intermittent Claudication (IC) Pluristem Therapeutics, Inc. announced the successful completion of a parallel scientific advisory process with the European Medical Agencies (EMA) and the U.S. Food and Drug Administration (FDA) regarding the Company’s planned clinical development program for PLX-PAD. [Pluristem Therapeutics, Inc. Press Release] Health Canada Requests Additional Information to Support Application for Approval of Prochymal Osiris Therapeutics, Inc. announced that Health Canada has requested additional information in support of the Company’s application for approval of Prochymal, a stem cell therapy, for the treatment of graft versus host disease. [Osiris Therapeutics, Inc. Press Release] Cancer Research UK and Cancer Research Technology Establish Team of Stem Cell Experts to Beat Cancer Cancer Research UK and its commercial arm, Cancer Research Technology, have established a team of scientists with expertise in cancer stem cell research to identify new targets to detect, monitor and treat cancer. The charity has hand-picked four world class research groups to collaborate on an initial two-year research project to unravel the role of cancer stem cells in the development, growth and spread of tumors in breast, prostate and head and neck cancers. [Cancer Research UK Press Release] Web Blood Matching Service An online matching service between donors and patients in need of a stem cell transplant is now available, Shanghai Cord Blood Bank announced. [Shanghai Daily]
|